HIV integrase inhibitors

Details for Australian Patent Application No. 2006315446 (hide)

Owner Bristol-Myers Squibb Company

Inventors Naidu, B. Narasimhulu; Walker, Michael A.; Ueda, Yasutsugu; Matiskella, John D.; Sorenson, Margaret E.

Agent A J Park

Pub. Number AU-A-2006315446

PCT Pub. Number WO2007/059229

Priority 60/737,062 16.11.05 US

Filing date 15 November 2006

Wipo publication date 24 May 2007

International Classifications

C07D 239/70 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/5383 (2006.01)

A61K 31/5386 (2006.01)

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 498/20 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

22 May 2008 PCT application entered the National Phase

  PCT publication WO2007/059229 Priority application(s): WO2007/059229

2 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006315448-Air freshening apparatus and method for increasing fragrance in headspace

2006315443-Photoactivatable antimicrobial agents